172 related articles for article (PubMed ID: 24656735)
1. Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?
Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
J Geriatr Oncol; 2014 Jul; 5(3):323-30. PubMed ID: 24656735
[TBL] [Abstract][Full Text] [Related]
2. Predictors of variation in colorectal cancer care and outcomes in New South Wales: a population-based health data linkage study.
Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
Med J Aust; 2014 Apr; 200(7):403-7. PubMed ID: 24794673
[TBL] [Abstract][Full Text] [Related]
3. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.
Ayanian JZ; Zaslavsky AM; Fuchs CS; Guadagnoli E; Creech CM; Cress RD; O'Connor LC; West DW; Allen ME; Wolf RE; Wright WE
J Clin Oncol; 2003 Apr; 21(7):1293-300. PubMed ID: 12663717
[TBL] [Abstract][Full Text] [Related]
4. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
Barton MB; Gabriel GS; Miles S
ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
[TBL] [Abstract][Full Text] [Related]
6. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
7. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
[TBL] [Abstract][Full Text] [Related]
8. Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.
Segelman J; Akre O; Gustafsson UO; Bottai M; Martling A
Colorectal Dis; 2014 May; 16(5):359-67. PubMed ID: 24410859
[TBL] [Abstract][Full Text] [Related]
9. Predictors of referral for adjuvant therapy for colorectal cancer.
Ong S; Watters JM; Grunfeld E; O'Rourke K
Can J Surg; 2005 Jun; 48(3):225-9. PubMed ID: 16013627
[TBL] [Abstract][Full Text] [Related]
10. Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer.
Earle CC; Weiser MR; Ter Veer A; Skibber JM; Wilson J; Rajput A; Wong YN; Benson AB; Shibata S; Romanus D; Niland J; Schrag D
J Surg Oncol; 2009 Dec; 100(7):525-8. PubMed ID: 19697351
[TBL] [Abstract][Full Text] [Related]
11. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy in colorectal cancer.
Parshad R
Trop Gastroenterol; 1997; 18(4):139-44. PubMed ID: 9612092
[TBL] [Abstract][Full Text] [Related]
13. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
[TBL] [Abstract][Full Text] [Related]
14. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
15. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
[TBL] [Abstract][Full Text] [Related]
16. Survival after pelvic exenteration for T4 rectal cancer.
Kusters M; Austin KK; Solomon MJ; Lee PJ; Nieuwenhuijzen GA; Rutten HJ
Br J Surg; 2015 Jan; 102(1):125-31. PubMed ID: 25451182
[TBL] [Abstract][Full Text] [Related]
17. Assessment of abdominoperineal resection rate as a surrogate marker of hospital quality in rectal cancer surgery.
Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
Br J Surg; 2013 Nov; 100(12):1655-63. PubMed ID: 24264791
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for colon and rectal cancer.
Ratkin GA
Am Fam Physician; 1997 May; 55(7):2487-92, 2495-6. PubMed ID: 9166147
[TBL] [Abstract][Full Text] [Related]
20. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
Eldin NS; Yasui Y; Scarfe A; Winget M
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
